Evaluating the targeting and therapeutic efficiency of alpha & beta emitting radiopharmaceuticals, through non-invasive in vivo screening
Time: 1:30 pm
day: Day 1 - Track A (PM)
Details:
- Preclinical in vivo imaging, serves as a gold-standard methodology for diagnostic radiopharmaceuticals evaluation
- Imaging of therapeutic isotopes (including a-emitters) is more challenging to establish and export relative data
- The proposed in vivo screening protocol, significantly enriches the study read-outs, during a standard preclinical drug efficacy study
